Skip to main content
. 2016 Autumn;7(4):253–259.

Table 2.

Comparison of parameters before and after receiving vitamin D supplements in patients with pulmonary artery hypertension and vitamin D deficiency

Parameters Before
N=22
After
N=21
P value
serum vitamin D level (ng/ml) 14.4(9.2) 69.2(31) <0.001*
serum Pro-BNP level (ng/ml) 436(47.6) 486(60.7) 0.66*
6MWT(meter) 259.9(124.3) 330.5(139.2) <0.001*
Pre6MWTO2Sat (%) 90.7(8.9) 90.5(8.4) 0.81*
Post6MWT O2Sat (%) 87.7(8.9) 88.9(9.4) 0.29*
EF (%) 53.8(3.9) 55.2(4) 0.14*
Peak-PAP(mmHg) 93.4(20.4) 92.41(24.8) 0.81*
Mean-PAP(mmHg) 79.75(24.92) 69.5(23.04) 0.07*
Functional Class (number (%)) 0.22**
I
II
III
IV
0
9(41%)
11(50%)
2(9%)
0
12(55%)
9(41%)
0
RV size (number (%)) 0.01**
Preserved
Mild enlargement
Moderate enlargement
Severe enlargement
1(4.5%)
2(9%)
5(22.7%)
14(63.8%)
2(9%)
4(19.1%)
5(23.8%)
10(48.1%)
RV Function (number (%)) 0.29**
Normal
Mild dysfunction
Moderate dysfunction
Severe dysfunction
4(18.3%)
6(27.3%)
8(36.1%)
4(18.3%)
6(28.5%)
6(28.5%)
6(28.5%)
3(14.5%)

Data are presented as mean (Standard deviation) and number (%); 6MWT: Six Minute Walk Test; O2Sat: Oxygen Saturation; EF: Ejection Fraction; PAP: Pulmonary Artery Pressure; Function class I = without limitation of physical activity, class II = slight limitation of physical activity, class III= marked limitation of physical activity, class IV = inability to carry on any physical activity without discomfort; RV: Right Ventricle;

*

Paired t-test;

* *

Wilcoxon test;